As of 2025-07-21, the Intrinsic Value of Sam Chun Dang Pharm Co Ltd (000250.KQ) is 15,656.27 KRW. This 000250.KQ valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 170,300.00 KRW, the upside of Sam Chun Dang Pharm Co Ltd is -90.80%.
The range of the Intrinsic Value is 9,924.71 - 46,503.16 KRW
Based on its market price of 170,300.00 KRW and our intrinsic valuation, Sam Chun Dang Pharm Co Ltd (000250.KQ) is overvalued by 90.80%.
Range | Selected | Upside | |
a | |||
DCF (Growth 5y) | 9,924.71 - 46,503.16 | 15,656.27 | -90.8% |
DCF (Growth 10y) | 14,500.60 - 67,647.28 | 22,875.66 | -86.6% |
DCF (EBITDA 5y) | 40,051.93 - 58,907.42 | 45,353.08 | -73.4% |
DCF (EBITDA 10y) | 42,150.78 - 67,696.88 | 49,984.17 | -70.6% |
Fair Value | -2,467.53 - -2,467.53 | -2,467.53 | -101.45% |
P/E | (7,047.30) - 17,138.62 | 2,142.91 | -98.7% |
EV/EBITDA | 10,362.00 - 38,421.34 | 22,313.65 | -86.9% |
EPV | (5,771.94) - (8,632.41) | (7,202.17) | -104.2% |
DDM - Stable | (6,327.69) - (42,798.11) | (24,562.92) | -114.4% |
DDM - Multi | 16,398.01 - 87,502.93 | 27,756.86 | -83.7% |
Market Cap (mil) | 3,995,238.00 |
Beta | 0.58 |
Outstanding shares (mil) | 23.46 |
Enterprise Value (mil) | 3,962,583.50 |
Market risk premium | 5.82% |
Cost of Equity | 7.25% |
Cost of Debt | 4.25% |
WACC | 7.20% |